Semi-Annual Statement Of Cash Flows

Chiome Bioscience Inc. - Filing #7270994

Concept As at
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2022-12-31
Semi-annual statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
-993,005,000 JPY
-1,071,232,000 JPY
Interest paid
-2,865,000 JPY
-2,069,000 JPY
Income taxes paid
-5,010,000 JPY
-5,010,000 JPY
Net cash provided by (used in) operating activities
-1,000,695,000 JPY
-1,069,192,000 JPY
Cash flows from investing activities
Proceeds from sale of property, plant and equipment
JPY
173,000 JPY
Net cash provided by (used in) investing activities
JPY
173,000 JPY
Cash flows from financing activities
Proceeds from issuance of bonds
250,000,000 JPY
JPY
Redemption of bonds
-250,000,000 JPY
JPY
Proceeds from issuance of shares
1,749,912,000 JPY
554,515,000 JPY
Net cash provided by (used in) financing activities
1,738,421,000 JPY
667,303,000 JPY
Other, net
JPY
0 JPY
Net increase (decrease) in cash and cash equivalents
737,725,000 JPY
-401,715,000 JPY
Cash and cash equivalents
2,063,280,000 JPY
1,325,554,000 JPY
1,727,270,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.